Mesoblast MESO
NASDAQ MESO
$17.32 +0.18 (+1.05%)
At close: Sep 4, 2026 · 4:00 PM EDT

Mesoblast (MESO) Other Working Capital Changes (2014 - 2025)

Mesoblast (MESO) posted Other Working Capital Changes of -$682000.0 for Q1 2023, down 55.35% sequentially from -$439000.0 in Q4 2022, and up 40.44% YoY from -$485628.1 in Q1 2022.

Analysis

Mesoblast (MESO) Other Working Capital Changes (2014 - 2025) Analysis & Trends

Mesoblast has reported Other Working Capital Changes for 8 years, with the latest figure at -$682000.0 in Q1 2023.

  • Quarterly Other Working Capital Changes rose 40.44% year-over-year to -$682000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was -$2.2 million (up 30.41% YoY) and the FY2022 annual result came in at -$2.8 million, up 4.88% from the prior year.
  • Other Working Capital Changes eased to -$682000.0 in Q1 2023 per MESO's latest filing, from -$439000.0 in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $2.4 million in Q1 2022 and troughed at -$3.3 million in Q4 2021.
  • A 5-year average of $294750.0 and a median of $1.0 million in 2020 frame the typical range for Other Working Capital Changes.
  • The sharpest annual moves came in 2020 and 2021: Other Working Capital Changes plunged 1084.48% in 2020, then soared 86.77% in 2021.
  • Over 5 years, Other Working Capital Changes stood at -$360000.0 in 2019, then sank by 118.06% to -$785000.0 in 2020, then soared by 32.74% to -$528000.0 in 2021, then grew by 16.86% to -$439000.0 in 2022, then plunged by 55.35% to -$682000.0 in 2023.
  • According to Business Quant data, Other Working Capital Changes over the past three periods registered -$682000.0, -$439000.0, and -$670000.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Mesoblast 2.24 Bn 2.14 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -3.02 Mn
Jun 30, 2025 -3.02 Mn
Sep 30, 2019 -164,000.00
Sep 30, 2019 -164,000.00
Sep 30, 2018 -251,000.00
Sep 30, 2018 -251,000.00
Sep 30, 2017 1.33 Mn
Sep 30, 2017 1.33 Mn
Sep 30, 2015 -227,000.00
Sep 30, 2015 -227,000.00
Sep 30, 2014 -641,000.00
Sep 30, 2014 -641,000.00